The State of Emerging Biotechs: Investment, Deal, and Pipeline Trends
4:15 PM - 4:45 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 208
![BIO International Convention](/sites/default/files/2021-09/_BIO_CONV_Logo-White.png)
David Thomas, BIO’s Senior Vice President of Industry Analysis, will provide an overview of recent investment and deal trends for emerging therapeutic companies, as well as an update on the R&D pipeline and recent FDA approvals. The BIO Industry Analysis team publishes quarterly interactive data on licensing, M&A, venture capital, IPOs, follow-on public offerings, and FDA approvals at www.bio.org/iareports.